Novadoz Pharmaceuticals primary commitment is to deliver safe, effective, and affordable generic pharmaceuticals to the market. Our employees unwavering focus on quality, ensures the patients who take our medications will have a reliable and trusted generic product source. The foundation of our company’s success is built on principles of integrity, and the strength of the relationships we maintain with our employees and customers.
Novadoz Pharmaceuticals is the U.S subsidiary of MSN Labs, a recognized worldwide leader in the development and manufacturing of API (Active Pharmaceutical Ingredient) and intermediates. MSN is #2 in the U.S for active DMFs (Drug Master Files). We are a vertically integrated organization from API R&D and Manufacturing, Product Formulation, and Finished Dosage Manufacturing.
Our vertical integration extends to key intermediates with backup manufacturing sites, to secure a reliable and consistent supply chain. Through the expertise of MSN’s product formulation & Intellectual Property teams, our company has a deep and extensive pipeline of oral solids, liquids, and injectable products. Our focus remains on high barrier of entry products that are complex to formulate and manufacture.
Novadoz offers value in every dose today, and as an emerging leader in the generic pharmaceutical industry.